Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04398264 · ClinicalTrials.gov registry record
Characteristics of COVID-19 Infection Among PREGnant Women
A clinical trial, sponsored by Inova Health Care Services.
- Completed
- Registry status
- 650
- Enrollment target
NCT04398264 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 650 participants.
The verdict
NCT04398264 has completed, sponsored by Inova Health Care Services.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
In December 2019, Coronavirus infection (COVID-19) was identified as causing serious respiratory infection in humans. Initially COVID-19 was propagated by infected symptomatic individuals; currently the disease is disseminated by asymptomatic COVID-19 positive subjects. The prevalence of asymptomatic COVID-19 individuals is unknown. Due its physiologic immune suppression, pregnancy is a vulnerable time for severe respiratory infections including COVID-19. Limited information is available regarding the impact of COVID-19 in pregnancy and the prevalence and demographic profile of asymptomatic pregnant women. Despite reports of 15-20% positive COVID-19 tests in women admitted to Labor and Delivery, professional obstetric medical societies still recommend not prioritizing testing of patients who are asymptomatic. In the USA, COVID-19 symptomatic patients come predominantly from lower income, Black and Latino communities. No data are available on the rate and demographic distribution of asymptomatic positive COVID-19 pregnant women. To minimize the risk of inadvertent exposure asymptomatic individuals, recently our institution started COVID-19 testing in all admitted pregnant women. The investigators expect to gain knowledge on the impact of COVID-19 in pregnant women especially if asymptomatic and compare to other respiratory infections.
Interventions
- OTHER COVID-19 positive via testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2021-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04398264
The ClinicalTrials.gov registry entry for NCT04398264 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 positive via testing is the first listed.
NCT04398264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04398264 about?
NCT04398264 is a clinical study titled "Characteristics of COVID-19 Infection Among PREGnant Women". In December 2019, Coronavirus infection (COVID-19) was identified as causing serious respiratory infection in humans. Initially COVID-19 was propagated by infected symptomatic individuals; currently the disease is disseminated by asymptomatic COVID-19 positive subjects. The prevalence of asymptomati...
What is the current status of trial NCT04398264?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2020-07-22. Estimated completion is 2021-03-31.
What interventions are being tested in trial NCT04398264?
The interventions under investigation include: COVID-19 positive via testing (OTHER).
Who is sponsoring clinical trial NCT04398264?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.